Product Code: 5061
Global blood transfusion devices market is expected to grow at a CAGR of around 6% during the forecast period. The global blood transfusion devices market is driven by upsurge in count of surgical procedures being carried out across the globe. Moreover, developments in terms of technology is expected to positively impact the growth of the market during the forecast period. Also, rise in number of blood related disorders is further expected to bolster the growth of market over the next few years.
The global blood transfusion devices market is segmented based on product, type, blood component, end user, company, and region. Based on product, the market can be categorized into apheresis systems, infusion devices, blood warmers, venous access devices, filters, and others. Out of these, the apheresis systems segment dominated the market in terms of largest market share until 2020 and is expected to maintain leading position in the market during the forecast period as well. This can be ascribed to its wide use for the treatment of leukostasis, which is caused by increased white blood count in leukaemia. In addition to this, apheresis system is also used for treating severe rheumatoid arthritis, in order to minimize the risk associated with antibody-mediated rejection of organ during, systemic lupus, goodpasture syndrome, polymyositis or dermatomycosis, and preeclampsia and eclampsia during pregnancy, which is anticipated to boost the growth of the segment over the coming years.
Major players operating in the global blood transfusion devices market include Fresenius Kabi AG, Grifols S.A., Terumo Corporation, B. Braun Melsungen AG, Becton, Dickinson, Company, Immucor Inc., Haemonetics Corporation, Kaneka Corporation, Macopharma SA, Tenko International Group Corp and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnerships, agreements, and new developments.
Years considered for this report:
- Historical Years: 2016-2019
- Forecast Period: 2022-2026
Objective of the Study:
- To analyze and estimate the market size of global blood transfusion devices market from 2016 to 2020.
- To estimate and forecast the market size of global blood transfusion devices market from 2021 to 2026 and growth rate until 2026.
- To classify and forecast global blood transfusion devices market based on product, blood component, end user, company and regional distribution.
- To identify dominant region or segment in the global blood transfusion devices market.
- To identify drivers and challenges for global blood transfusion devices market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global blood transfusion devices market.
- To conduct pricing analysis for global blood transfusion devices market.
- To identify and analyze the profile of leading players operating in global blood transfusion devices market.
- To identify key sustainable strategies adopted by market players in global blood transfusion devices market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers and presence of all major players across the globe.
TechSci Research calculated the market size of global blood transfusion devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Blood transfusion devices manufacturers, suppliers and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to blood transfusion devices
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global blood transfusion devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Global Blood Transfusion Devices Market, By Product:
Apheresis Systems
Infusion Devices
Blood Warmers
Venous Access Devices
Filters
Others
- Global Blood Transfusion Devices Market, By Blood Component:
Whole Blood
Plasma
RBC
Others
- Global Blood Transfusion Devices Market, By End User:
Hospital
Ambulatory Surgical Centers
Dialysis Centers
Blood Bank
Other
- Global Blood Transfusion Devices Market, By Region:
North America
- United States
- Canada
- Mexico
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
South America
- Brazil
- Argentina
- Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global blood transfusion devices market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Blood Transfusion Devices Market
4. Executive Summary
5. Voice of Customer
6. Global Blood Transfusion Devices Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)
- 6.2.2. By Blood Component (Whole Blood, Plasma, RBC, Others)
- 6.2.3. By End User (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Other)
- 6.2.4. By Company (2020)
- 6.2.5. By Region
- 6.3. Product Market Map
7. Asia-Pacific Blood Transfusion Devices Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Blood Component
- 7.2.3. By End User
- 7.2.4. By Country
- 7.3. Asia-Pacific: Country Analysis
- 7.3.1. China Blood Transfusion Devices Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Product
- 7.3.1.2.2. By Blood Component
- 7.3.1.2.3. By End User
- 7.3.2. India Blood Transfusion Devices Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Product
- 7.3.2.2.2. By Blood Component
- 7.3.2.2.3. By End User
- 7.3.3. Australia Blood Transfusion Devices Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Product
- 7.3.3.2.2. By Blood Component
- 7.3.3.2.3. By End User
- 7.3.4. Japan Blood Transfusion Devices Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Product
- 7.3.4.2.2. By Blood Component
- 7.3.4.2.3. By End User
- 7.3.5. South Korea Blood Transfusion Devices Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Product
- 7.3.5.2.2. By Blood Component
- 7.3.5.2.3. By End User
8. Europe Blood Transfusion Devices Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Blood Component
- 8.2.3. By End User
- 8.2.4. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Blood Transfusion Devices Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Product
- 8.3.1.2.2. By Blood Component
- 8.3.1.2.3. By End User
- 8.3.2. Germany Blood Transfusion Devices Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Product
- 8.3.2.2.2. By Blood Component
- 8.3.2.2.3. By End User
- 8.3.3. United Kingdom Blood Transfusion Devices Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Product
- 8.3.3.2.2. By Blood Component
- 8.3.3.2.3. By End User
- 8.3.4. Italy Blood Transfusion Devices Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Product
- 8.3.4.2.2. By Blood Component
- 8.3.4.2.3. By End User
- 8.3.5. Spain Blood Transfusion Devices Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Product
- 8.3.5.2.2. By Blood Component
- 8.3.5.2.3. By End User
9. North America Blood Transfusion Devices Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Blood Component
- 9.2.3. By End User
- 9.2.4. By Country
- 9.3. North America: Country Analysis
- 9.3.1. United States Blood Transfusion Devices Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Product
- 9.3.1.2.2. By Blood Component
- 9.3.1.2.3. By End User
- 9.3.2. Mexico Blood Transfusion Devices Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Product
- 9.3.2.2.2. By Blood Component
- 9.3.2.2.3. By End User
- 9.3.3. Canada Blood Transfusion Devices Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Product
- 9.3.3.2.2. By Blood Component
- 9.3.3.2.3. By End User
10. South America Blood Transfusion Devices Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Blood Component
- 10.2.3. By End User
- 10.2.4. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Blood Transfusion Devices Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Product
- 10.3.1.2.2. By Blood Component
- 10.3.1.2.3. By End User
- 10.3.2. Argentina Blood Transfusion Devices Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Product
- 10.3.2.2.2. By Blood Component
- 10.3.2.2.3. By End User
- 10.3.3. Colombia Blood Transfusion Devices Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Product
- 10.3.3.2.2. By Blood Component
- 10.3.3.2.3. By End User
11. Middle East and Africa Blood Transfusion Devices Market Outlook
- 11.1. Market Size & Forecast
- 11.2. Market Share & Forecast
- 11.2.1. By Product
- 11.2.2. By Blood Component
- 11.2.3. By End User
- 11.2.4. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Blood Transfusion Devices Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Product
- 11.3.1.2.2. By Blood Component
- 11.3.1.2.3. By End User
- 11.3.2. Saudi Arabia Blood Transfusion Devices Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Product
- 11.3.2.2.2. By Blood Component
- 11.3.2.2.3. By End User
- 11.3.3. UAE Blood Transfusion Devices Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Product
- 11.3.3.2.2. By Blood Component
- 11.3.3.2.3. By End User
- 11.3.4. Kuwait Blood Transfusion Devices Market Outlook
- 11.3.4.1. Market Size & Forecast
- 11.3.4.2. Market Share & Forecast
- 11.3.4.2.1. By Product
- 11.3.4.2.2. By Blood Component
- 11.3.4.2.3. By End User
12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
- 14.1. Competition Outlook
- 14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
- 14.2.1. Fresenius Kabi AG
- 14.2.2. Grifols S.A.
- 14.2.3. Terumo Corporation
- 14.2.4. B. Braun Melsungen AG
- 14.2.5. Becton, Dickinson, and Company
- 14.2.6. Immucor Inc.
- 14.2.7. Haemonetics Corporation
- 14.2.8. Kaneka Corporation
- 14.2.9. Macopharma SA
- 14.2.10. Tenko International Group Corp
15. Strategic Recommendations
16. About Us & Disclaimer